| Jillian Lake, | |
|
808 5th Ave, Des Moines, IA 50309-1307 | |
| (515) 244-2267 | |
| Not Available |
| Full Name | Jillian Lake |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 808 5th Ave, Des Moines, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023628724 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 101688 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jillian Lake, 105 Bradford Rd Ste 400, Wexford, PA 15090-6920 Ph: () - | Jillian Lake, 808 5th Ave, Des Moines, IA 50309-1307 Ph: (515) 244-2267 |
News Archive
A new study posted to the medRxiv* preprint server explores environmental surveillance of elementary school settings for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) through wastewater and surface samples monitoring. The researchers demonstrated that 93% of the COVID-19 cases in public elementary schools could be identified using this method.
Sequenom, Inc., today announced an exclusive worldwide licensing agreement with Optherion, Inc. Under the agreement, Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center for Molecular Medicine (Sequenom CMM), obtained the rights to develop and commercialize diagnostic tests to predict genetic predisposition to late stage age-related macular degeneration (AMD).
Prolias, a biotechnology company working to discover and develop novel therapeutic proteins and antibodies for treatment of disease, today announced a strategic acquisition of technology from the University of Maryland Biotechnology Institute (UMBI).
Scientists from RIKEN in Japan have discovered that acrolein—a toxic substance produced in cells during times of oxidative stress—in fact may play a role in preventing the process of fibrillation, an abnormal clumping of peptides that has been associated with Alzheimer's disease and other neural diseases.
Biodesix, Inc., a company developing and commercializing molecular diagnostics for personalized medicine, announced today that the United States Patent and Trademark Office has awarded to the Company patent number 7,736,905. The patent provides coverage for the Company's first product, VeriStrat®, which is used by physicians to help guide therapy for patients with advanced lung cancer. The allowed claims are directed towards the serum-based identification of patients likely to benefit from epidermal growth factor targeted therapy.
› Verified 2 days ago
Martha Diaz, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 808 5th Ave, Des Moines, IA 50309 Phone: 515-244-2267 | |
Gladys Noll Alvarez, L.I.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 808 5th Ave, Des Moines, IA 50309 Phone: 515-244-2267 | |
Angie Appelgate, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 808 5th Ave, Des Moines, IA 50309 Phone: 515-244-2267 | |
Janelle Kamba, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3200 Ingersoll Ave Ste E, Des Moines, IA 50312 Phone: 515-729-2019 | |
Rachel Nicole Ukena, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3600 30th St, Des Moines, IA 50310 Phone: 515-699-5999 | |
Jennifer Lynn Roberts, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2708 Grand Ave, Des Moines, IA 50312 Phone: 515-778-4592 |